Background/Aims: ATP-gated P2X 4 purinergic receptors (P2X 4 Rs) are cation channels with important roles in diverse cell types. To date, lack of specific inhibitors has hampered investigations on P2X 4 Rs. Recently, the benzodiazepine derivative, 5-BDBD has been proposed to selectively inhibit P2X 4 Rs. However, limited evidences are currently available on its inhibitory properties. Thus, we aimed to characterize the inhibitory effects of 5-BDBD on recombinant human P2X 4 Rs. Methods: We investigated ATP-induced intracellular Ca 2+ signals and whole cell ion currents in HEK 293 cells that were either transiently or stably transfected with hP2X 4 Rs. Results: Our data show that ATP (< 1 μM) stimulates P2X 4 R-mediated Ca 2+ influx while endogenously expressed P2Y receptors are not activated to any significant extent. Both 5-BDBD and TNP-ATP inhibit ATP-induced Ca 2+ signals and inward ion currents in a concentration-dependent manner. Application of two different concentrations of 5-BDBD causes a rightward shift in ATP dose-response curve. Since the magnitude of maximal stimulation does not change, these data suggest that 5-BDBD may competitively inhibit the P2X 4 Rs. Conclusions: Our results demonstrate that application of submicromolar ATP concentrations allows reliable assessment of recombinant P2XR functions in HEK 293 cells. Furthermore, 5-BDBD and TNP-ATP have similar inhibitory potencies on the P2X 4 Rs although their mechanisms of actions are different.
Investigation of the

Introduction
Extracellular ATP and its breakdown products regulate a number of cellular functions by stimulating purinergic receptors [1] . In the last two decades 19 different purinergic receptors have been identified including four adenosine-activated P1 receptors, seven ATPgated P2X receptor (P2XR) channels and eight metabotropic P2Y receptors which can be stimulated by adenosine and uridine tri-and diphosphates [2] .
The seven P2X receptor subunits (P2X 1-7 ) are widely distributed in both excitable and non-excitable cells providing cation permeable pathways (mainly for Ca 2+ and Na + ) through the plasma membrane. Previous studies revealed that these subunits might assemble as either homo-or heterotrimeric receptors [2] . Importantly, heteromerization can change functional and pharmacological properties of the P2XRs [2] . P2XRs are involved in presynaptic and postsynaptic actions of ATP [3] [4] [5] including taste sensation [6] , hearing [7] and chemoreception [8] . P2XRs are also necessary for proper function of immune system [9] . In cardiovascular, respiratory, genitourinary and gastrointestinal systems several P2X receptor subunits seem to play pivotal role in both endothelial and epithelial cell functions [10] . Using pharmacological approaches and knockout animals, it has also become evident that P2XRs are involved in a broad range of pathophysiological processes such as chronic and inflammatory pain [11] [12] [13] [14] [15] arthritis [16] male infertility [17] and hypertension [18, 19] .
A role for P2X 4 receptors has been proposed in neuropathic pain [15] , endothelial NO production [18] , regulation of airway ciliary epithelia [20] and chloride secretion of respiratory [21, 22] and biliary epithelia [23] . However, validation of P2X 4 R involvement has been often hampered by the lack of specific inhibitors. In fact, P2X 4 receptors are insensitive to the nonselective inhibitors, such as suramin and PPADS [24] . TNP-ATP has been found as a putative antagonist of P2X 4 receptors. However, it blocks other P2X subtypes as well, such as P2X 1 , P2X 2 and P2X 3 [25] . Furthermore, TNP-ATP has been shown to be a weak blocker of P2X 4 receptors (IC 50 = 15 μM for 10 μM ATP stimulation) compared to its inhibitory potency at P2X 1 and P2X 3 receptors [26] .
The benzodiazepine derivative, 5-(3-bromophenyl)-1,3-dihydro-2H-benzofuro[3,2-e]-1,4-diazepin-2-one (5-BDBD), has been recently shown to selectively inhibit P2X 4 receptors (IC 50 ~ 0.5 µM) [27] . Nonetheless, these results are described in a patent and details of the experimental procedure are not available. So far, limited experience has been available with 5-BDBD and there is no consensus about its pharmacologically relevant concentration range. In some studies low micromolar (5-10 μM) concentrations were used [28, 29] whereas others applied significantly higher doses of 5-BDBD (30-100 μM) [30, 31] .
In the present study, we investigated ATP-induced cytosolic Ca 2+ signals and inward ion currents in HEK 293 cells transfected either transiently or stably with hP2X 4 receptors. We characterized P2X 4 receptor-mediated whole cell ion currents and identified P2YR-and P2XR-dependent calcium signals using electrophysiological and fluorescence ion measurement techniques, respectively. Despite endogenous expression of P2YRs we were able to discern P2XR-dependent Ca 2+ signals stimulating the cells with submicromolar concentrations of ATP. We also assessed the inhibitory effects of 5-BDBD and TNP-ATP on both intracellular Ca 2+ signals and inward ion currents. Our data suggest that 5-BDBD and TNP-ATP have similar inhibitory potencies on P2X 4 Rs. Furthermore, we show that 5-BDBD functions as a competitive antagonist of hP2X 4 Rs.
Materials and Methods
Materials
Cell culture medium, fetal bovine serum, cell culture supplements and antibiotics were purchased from Csertex Inc. (Budapest, Hungary). TurboFect™ in vitro Transfection Reagent was purchased from Biocenter (Szeged, Hungary). Lipofectamine 2000 was obtained from Invitrogen (Life Technologies Europe B.V, Zug, Switzerland). Fluo-3/AM was purchased from Invitrogen Inc. (Carlsbad, CA). 5-BDBD was obtained
DNA Construct
The human P2X 4 R (imaGenes GmbH, Berlin, Germany) was amplified from human cDNA with the following primer pair: 5 '-TAT AAG ATC TCG CGG CCA TGG CGG GC-3',  5'-TAT AGA ATT CCC TGG TCC AGC TCA CTA GCA AGA CCC TGC-3' The amplified product was subcloned into the pmCherry-N1 (Clontech Laboratories Inc.) vector by using BglII and EcoRI restrictions sites. Amino acid sequence of the human P2X 4 receptors fully corresponds to the isoform 3 described in gene database of the National Institute of Health.
Cell culture and establishment pmCherry-N1-hP2X 4 expressing HEK 293 cell clones Human embryonic kidney (HEK) 293 cells were grown in plastic tissue culture flasks in DMEM/ Ham's F-12 (1:1) medium supplemented with 5% fetal bovine serum, 100 U/ml penicillin and 100µg/ ml streptomycin at 37°C in a cell culture incubator supplied with 5% CO 2. Cells were subcultivated when confluency reached 90-95%. To establish pmCherry-N1-hP2X4 expressing HEK 293 cell clones, cells plated the day before on poly-D-lysine coated 35 mm dish were transfected with 2 µg pmCherry-N1-hP2X 4 using 5 µl Lipofectamine 2000 per well as described in the manufacturer's protocol. Transfection medium was changed to antibiotic-free medium after 4 hours. On the following day the medium was then changed with selection antibiotic (G418) containing medium. From then on, the cells were kept in this selection medium. After a massive cell death of the non-transfected cells, surviving cells were trypsinized and replated in a 96-well plate at such a dilution that 1 cell/well density was obtained. After several days, colonies of cells displaying red fluorescence were selected as hP2X 4 -expressing positive clones using fluorescence microscopy.
Transient transfection
Before the day of transfection, cells were plated on poly-D-lysine coated round glass coverslips (25 mm in diameter) at a density of 500,000 cells in 40 mm plastic Petri dishes. After 16-24 h, cells were transfected with 3µg pmCherry-N1-hP2X 4 DNA and 5µl of TurboFect™ transfection reagent in 200µl of serum-free medium. Cells were subjected to experiments 16-48 h after transfection. The efficiency of transfection was 60-70%.
Cell surface biotinylation and western blotting P2X 4 expressing HEK 293 cell clones were plated at 1.000.000 cell density into poly-D-lysine coated 60 mm dishes. 24 hours after plating, cells were rinsed with ice-cold PBS-Ca-Mg (PBS containing 0.1 mM CaCl 2 and 1 mM MgCl 2 ) followed by biotinylation of proteins at the plasma membrane with 1.5 mg/ml sulfo-NHS-LC-biotin in 10 mM triethanolamine (pH 7.4), 1 mM MgCl 2 , 2 mM CaCl 2 , and 150 mM NaCl for 90 minutes with horizontal shaking at 4°C. Next, excess biotin was quenched with PBS containing 1 mM MgCl 2 , 0.1 mM CaCl 2 , and 100 mM glycine for 20 minutes at 4°C, and then rinsed three times with PBS. Cells were finally lysed in lysis buffer for 30 minutes and lysates were cleared by centrifugation. Protein concentrations were determined by DC Protein Assay. Portion of cell lysates of equivalent amounts of protein (1.33 mg/ml) were equilibrated overnight with streptavidin agarose beads at 4°C. Beads were washed sequentially with solutions A [50 mM Tris·HCl (pH 7.4), 100 mM NaCl, and 5 mM EDTA] three times, B [50 mM Tris·HCl (pH 7.4) and 500 mM NaCl] twice, and C (50 mM Tris·HCl, pH 7.4) once. Biotinylated surface proteins were then released by heating to 95°C with 4x Laemmli buffer. Proteins from the intracellular fraction were also heated to 95°C for 5 minutes with 4x Laemmli buffer.
Samples were run on a 10% SDS gel with 40 µl protein loaded from the cytosolic protein (1 mg/ml) and the plasma membrane samples. Samples were transferred onto a PVDF membrane in Towbin's buffer using the semi-dry transfer method. Membranes were blocked with PBS containing 5% milk, 0.5% BSA and 0.02% NaN 3 at room temperature for 1 hour. Afterwards, samples were incubated in blocking solution containing the appropriate primary antibody (1:1000 for mouse anti-mCherry (Clontech, 632543)) at 4°C for overnight followed by three washes with PBST. HRP-conjugated goat anti-mouse antibody (1:4000, BioRad) was used as secondary antibody. After three consecutive washes with PBST and a final wash with PBS, the enhanced chemiluminescence (ECL) method was used for detection. For loading control the membrane probed with anti-mCherry was stripped and blotted with avidin-HRP (1:1000, BioRad).
Histochemistry
After 24 hours of plating 400.000 P2X 4 -expressing HEK 293 clonal cells into a 35 mm dish, cells were washed thoroughly with PBS. Next, cells were incubated with 0.1 mg/ml LC-sulfo-NHS(+)-biotin (Molbio) at room temperature for 1 hour followed by three washes with PBS. Thereafter, cells were fixed with 4% PFA at 37 0 C for 15 minutes. Cells were washed three times with PBS before staining with Streptavidin conjugated to Alexa 488 (1:4000 dilution, Invitrogen) at room temperature for one hour. After washing the cells four times with PBS, samples were mounted with CitiFluor AF2 (EMS). Images were captured with a Nikon C1 confocal laser scanning microscopy system equipped with Multiline Argon and HeNe lasers using 40x magnification. 
Measurement of intracellular calcium levels
Fluorescence ion measurement experiments using FLIPRTetra
Cells were trypsinized and plated at 40,000 cells/well density in 100 µl volume onto 96-well black plates coated with 100µg/ml poly-D-lysine 36 hours before the experiments. HEK 293 cells were used for testing the effects of compounds on endogenous P2Y receptors; whereas P2X 4 activity was measured using P2X 4 -expressing HEK 293 cell clones. 36 hours later the medium was replaced with 100 µl of loading buffer (modified Krebs buffer containing 117 mM NaCl, 4,8 mM KCl, 1 mM CaCl 2 ,1 mM MgCl 2 , 5 mM D-glucose, 10 mM HEPES, and Calcium-5 fluorescence dye). Cells were then incubated in the loading buffer at 37 o C for one hour. Fluorescence calcium measurements were carried out using FLIPTetra high-throughput, fluorescence microplate reader. Cells were excited using a 470-495 nm LED module, and the emitted fluorescence signal was filtered with a 515-575 nm emission filter. After establishment of a stable baseline, cells were incubated with the compounds for five minutes followed by the administration of ATP with or without the tested compounds.
Electrophysiology
Voltage-clamp recordings were carried out in the standard whole-cell configuration using an Axopatch 200B amplifier (Axon Instruments) [32] . Human P2X 4 -expressing cells were selected using a Diaphot 300 inverted patch clamp microscope (Nikon) equipped with an epifluorescent attachment (Elektro-Optika, Érd, Hungary). Micropipettes were pulled by a P-97 Flaming-Brown type micropipette puller (Sutter Instrument) from borosilicate glass capillary tubes (Harvard Apparatus) and had a tip resistance of 3-6 MΩ when filled with pipette solution. Patch pipette filling solution contained (in mM): 135 KCl, 5 NaCl, 1 MgCl 2 , 1 EGTA, 10 HEPES and an appropriate concentration of CaCl 2 , to give free [Ca
] i was estimated using MaxChelator software (Stanford University, Palo Alto, USA). The pH was adjusted to 7.2 with KOH. Standard extracellular solution contained (in mM): 145 NaCl, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 D-glucose, 10 HEPES, pH 7.4 (with NaOH). Solutions were delivered by continuous perfusion with a gravityfed delivery system. Antagonists were added to the bath solutions 3-5 min. prior to agonist application.
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Experiments were performed at a holding potential of -60 mV. Command protocols and data acquisition were controlled by pClamp 6.03 software (Axon Instruments). Capacitative currents were compensated with analog compensation. Series resistance was accepted if lower than five times the pipette tip resistance. Analog data were filtered at 1 kHz with a low-pass Bessel filter and digitized at 5 kHz using a Digidata 1200 interface board. Data were analyzed using Clampfit 6.03 and Microsoft Excel softwares. All experiments were performed at room temperature.
Data presentation
Areas under the curve (AUC) values were calculated using the trapezoidal rule, in the first 4 minutes following agonist application (SigmaPlot 12.0 software). To estimate P2X receptor function, non-expressing cell responses were subtracted from the AUC values obtained in P2X 4 R expressing cells on the same coverslip.
Antagonist concentration-inhibition curves were obtained by using progressively increasing antagonist concentrations and a fixed agonist concentration close to the EC 50 unless otherwise stated. IC 50 values were calculated by least squares fitting to
], where I and I 0 represent peak responses in the presence and absence of antagonist at concentration [Ant] .
Results were presented as means ± SEM of n observations if not otherwise indicated. Statistical significance was determined using paired Student's t-test for parametric, whereas one-way ANOVA followed by Mann-Whitney U test for non-parametric variables. Differences were considered statistically significant when p < 0.05. Non-linear curve fitting was performed using the SigmaPlot 12.0 program.
Results
Localization and functional characterization of transfected hP2X 4 receptors in HEK 293 cells
In order to study the localization of transfected hP2X 4 receptors in HEK 293 cells we used immunohistochemical techniques. Co-localization of biotinylated cell surface proteins and mCherry fluorescent protein suggested the expression of P2X 4 Rs in the plasma membrane (Fig. 1) . Furthermore, cell surface biotinylation and western blotting were used to separate the cytosolic and membrane fractions of proteins in HEK 293 cells. The P2X 4 -bound mCherry protein was detected at the plasma membrane and its expression was not altered by the presence of ivermectin ( Fig. 2A) . In control experiment we used avidin-HRP-conjugated antibody to confirm the localization of proteins in the membrane fraction (Fig. 2B) . 
To functionally characterize the plasma membrane localized hP2X 4 receptors we measured whole cell currents in transfected HEK 293 cells. ATP (0.1-300 μM) elicited increasing maximal current amplitudes in cells expressing P2X 4 Rs (Fig. 2C and D) . The agonist concentration-response curve for ATP were fit with the Hill-equation
nH ] where E stands for the peak current evoked by agonist concentration [A], E max is the peak current evoked by a maximal agonist concentration, EC 50 is the concentration giving half the maximal current, and nH represents the Hill coefficient. Our results showed that the EC 50 value of ATP was 2.1 μM (Fig. 2D) . Cells lacking P2X 4 R expression failed to respond to ATP (100 μM) (data not shown). To confirm the role of P2X 4 Rs in ATP-induced inward currents we pretreated the cells with ivermectin (IVM) (3 and 10 μM). As expected, IVM potentiated currents induced by ATP (0.5 μM) in a concentration-dependent manner (Fig.  2E) . In addition, we tested the effects of TNP-ATP on ATP-induced (1 μM) currents. Under these conditions, we found that the half-maximal inhibitory concentration (IC 50 ) of TNP-ATP was 1.5 μM (Fig. 2F) . These data show the plasma membrane localized hP2X 4 receptors are fully functional in transfected HEK 293 cells. 
ATP-induced Ca 2+ influx is inhibited by 5-BDBD in cells stably expressing P2X 4 Rs
In native HEK 293 cells ATP (0.5-100 μM) caused transient increases in cytosolic calcium concentrations whereas lower doses of the agonist (0.1-0.25 μM) elicited no change in calcium levels ( Fig 3A) . In nominally calcium-free buffer ATP (0.1-100 μM) caused similar effects suggesting that the calcium signal was due to P2Y receptor-dependent Ca 2+ release from the intracellular stores (Fig. 3B) . Although the presence of external Ca 2+ prolonged ATP-induced calcium signals, sustained responses could not been observed (Fig. 3A) . Next, we studied ATP-induced Ca 2+ signals in HEK 293 cell clones stably expressing P2X 4 Rs (see methods). In these cells ATP (0.1-0.25 μM) elicited changes in Ca 2+ concentrations that were abolished in Ca
2+
-depleted medium indicating that Ca 2+ entered the cells from the extracellular space ( Fig.  3C and D) . In addition, higher concentrations of ATP (≥ 1μM) caused sustained Ca 2+ signals (Fig. 3C) . Importantly, the P2X 4 receptor-specific positive allosteric modulator IVM (20 μM) potentiated the ATP-induced (0.25 μM) Ca 2+ entry (AUC ATP = 852 ± 47; n=5 vs. AUC ATP+IVM = 1026 ± 46; n=5; p<0.05). These data indicate that using low concentrations of ATP (≤0.25 μM) allows assessment of P2X 4 R-mediated Ca 2+ signals independent of P2Y receptor activation. Thus, we next studied the effects of the benzodiazepine derivative 5-BDBD in the presence of 0.25 μM ATP. Under these conditions 5-BDBD (2-20 μM) significantly inhibited P2X 4 Rmediated Ca 2+ entry (Fig. 4A) . We obtained similar inhibitory effects of 5-BDBD when cells were stimulated by 0.5 μM ATP (Fig. 4B) . Regardless of ATP concentrations used, 5-BDBD (1-20 μM) had no effects in native HEK 293 cells suggesting that endogenously expressed P2Y receptors were not inhibited (data not shown). 
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Single cell calcium imaging in cells transiently expressing P2X 4 Rs
Single cell calcium imaging has been shown to provide an alternative method for the assessment of P2X receptor channel activity [33] . Therefore, we also studied the ATPinduced intracellular Ca 2+ signals at the single cell level. In order to conduct simultaneous measurements of cytosolic Ca 2+ levels in P2X 4 R-expressing and non-expressing cells, we used (Fig. 5A ). In cells expressing P2X 4 Rs, the magnitude of Ca 2+ peaks induced by 0.1 μM and 0.5 μM ATP were significantly higher than in non-expressing cells. However, robust Ca 2+ plateau was induced only by 0.5 μM ATP (Fig. 5A) . Further increasing ATP concentrations (1 μM), a considerable rise in cytosolic Ca 2+ peak was observed in cells lacking P2X 4 R expression. In contrast, the sustained component of the Ca 2+ signal induced by 1 μM ATP did not significantly differ from that elicited by 0.5 μM ATP in P2X 4 R expressing cells (Fig. 5A) . Consequently, as P2XR:P2YR-mediated Ca 2+ response ratio was the highest at 0.5 μM ATP (Fig. 5B) (Fig. 6 ). In cells lacking P2X 4 R expression, external Ca 2+ did not influence the ATP-induced transient nature of cytosolic Ca 2+ signal (Fig. 6 ). These data excluded the possibility that store-operated calcium channels played significant role in Ca 2+ entry when cells were stimulated with 0.5 μM ATP. To further characterize the sustained Ca 2+ signal, we pretreated the cells with IVM (10 μM) 5 min prior the application of ATP. Our results showed that ATP-induced Ca 2+ plateau was significantly elevated in P2X 4 R expressing but not in non-expressing cells (Fig. 6 ).
Next, we tested the effects of 5-BDBD on ATP-induced (0.5 μM), P2X 4 R-mediated Ca (Fig. 7A) . We also studied inhibitory effects of TNP-ATP which was reported as a putative antagonist of P2X 4 Rs [25] . As shown in Figure 7B , TNP-ATP (0.5-50 μM) reduced ATP-induced (0.5 μM) sustained Ca 2+ signal in a concentration-dependent manner. Taken together, these data indicate that ATP-induced sustained Ca 2+ signals were inhibited by both 5-BDBD and TNP-ATP in HEK 293 cells transfected with P2X 4 Rs. (Fig. 8A and B) . To investigate whether the inhibitory effect of 5-BDBD was due to competitive or allosteric interaction with P2X 4 Rs, we performed additional electrophysiological experiments. Application of two different concentrations of 5-BDBD (2 µM and 20 µM) caused a rightward shift in ATP dose-response curve (from EC 50 = 2.1 µM to 11.2 µM and 79.2 µM, respectively, using non-linear regression analysis). Since the magnitude of maximal stimulation did not change, these data suggest that 5-BDBD competitively inhibited the P2X 4 Rs (Fig. 8C) .
Discussion
P2X 4 receptors are involved in important physiological and pathophysiological functions such as afferent signalling, chronic pain and autocrine/paracrine communications of endothelial and epithelial cells. In these processes, investigations on the role of P2X 4 Rs are often hindered by lack of selective inhibitors. In recent years, considerable efforts have been made to discover novel effective antagonists of P2X 4 Rs. Although the benzodiazepine derivative 5-BDBD has been recently proposed to selectively block P2X 4 Rs [27] , only limited experiences have been available concerning its inhibitory properties [28] [29] [30] [31] . Moreover, to the best of our knowledge, there are no previous studies attempting to compare the inhibitory effects of 5-BDBD using both electrophysiological and intracellular calcium measurements. Therefore, we aimed to investigate the inhibitory potency of 5-BDBD on P2X 4 R-dependent Ca 2+ entry. Our data provide evidence for competitive though moderate inhibitory effects of 5-BDBD. Depending on experimental conditions the degree of inhibition varied significantly. In patch clamp experiments, assessing the effects of 5-BDBD directly on its target protein, we obtained the strongest inhibition. In intracellular calcium measurements, 5-BDBD exhibited more robust effects in transiently transfected cells. This was probably due to both the higher level of P2X 4 R expression and the single cell calcium measurements. However, it is important to emphasis that AUC values are not in a linear fashion with [Ca 2+ ] i and quantitative analyses of fluorometric Ca 2+ assay may provide only a rough orientation. Despite the endogenous expression of at least three different P2Y receptor subtypes [34, 35] HEK 293 cells are frequently used to study properties of P2X receptors [34, 36] . To assess the role of P2XRs in inducing changes of intracellular Ca 2+ concentrations, some investigators often choose cell lines (i.e. excitable mouse immortalized gonadotropinreleasing hormone-secreting cells (GT1) and human astrocytoma cells (1321N1)) that are lacking P2Y receptors [33, 37] 2+ concentration whereas 1 μM ATP significantly enhances the signal amplitude in non-expressing cells. This phenomenon was probably due to the gradual activation of different endogenous P2Y receptor subtypes [35] .
To our surprise, we found that amplitudes of ATP-induced Ca 2+ signals were significantly higher in P2X 4 R-expressing than in non-expressing cells when experiments were performed in Ca
2+
-depleted medium (Fig. 6 ). Since we obtained similar results in stably transfected cells as well, we speculate that the difference was due to P2X 4 R-mediated Ca 2+ entry rather than additional release of Ca 2+ from the internal stores. High levels of P2X 4 R-expression and lack of Ca 2+ -chelation could both contribute to the Ca 2+ entry. Furthermore, our data show that IVM enhances the ATP-induced Ca 2+ entry only in P2X 4 R-expressing cells. In accordance with previous observations, IVM potentiated ATP-induced Ca 2+ entry but did not increase surface expression of P2X4Rs [38, 39] .
Our electrophysiological data confirmed the presence of functional P2X 4 Rs in transiently transfected HEK 293 cells. ATP caused IVM-sensitive activation of inward currents in P2X 4 R-expressing but not in non-expressing cells. We found EC 50 value of ATP close to what was previously reported [26] . However, it is noteworthy that, in some experiments ATPstimulated currents exhibited incomplete recovery following withdrawal of the agonist when its concentration was higher than 1 µM. This was probably due to the high level of P2X 4 R expression and massive Ca 2+ influx which could consequently cause cellular damage. Therefore, inhibitory properties of both TNP-ATP and 5-BDBD were tested at 1 µM ATP stimulation.
Activation of P2X 4 Rs plays a key role in the pathogenesis of neuropathic pain [15] . In an attempt to mitigate the neuropathic pain Inoue and his colleagues investigated the possible role of antidepressants as inhibitors of P2X 4 Rs [37] . They found that paroxetine inhibited P2X 4 Rs dose-dependently. Paroxetine behaved as a noncompetitive antagonist with IC 50 values of 2.5 µM and 1.9 µM for rat and human P2X 4 Rs, respectively. Interestingly, inhibitory effects of paroxetine were significantly stronger on rat P2X 4 Rs than that of TNP-ATP [37] . It is known that TNP-ATP is more than 1,000-fold more potent in blocking P2X 1 and P2X 3 than P2X 4 receptors [24] . Nonetheless, TNP-ATP has been used as P2X 4 antagonist in a number of studies [40, 41] . Our data also demonstrate that TNP-ATP inhibits both intracellular Ca 2+ signals and inward ion currents induced by ATP. We found that TNP-ATP had an IC 50 value of 1.5 µM for 1 µM ATP stimulation which was comparable with previous observations [25] . Noncompetitive antagonism of TNP-ATP at the P2X 3 Rs suggests similar mechanisms of action at P2X 4 Rs as well [25] .
Recently, 5-BDBD has been proposed to selectively inhibit P2X 4 Rs [27] . Since then 5-BDBD has been used in a number of studies with contradictory results [28] [29] [30] [31] . It has weak potency to inhibit recombinant human P2X 4 Rs [28] or native P2X 4 Rs in vascular endothelial cells (IC 50 ~ 30 µM) [30] . In contrast, P2X 4 Rs were potently blocked by 10 µM 5-BDBD in prechondrogenic cell line [29] . Here we report that 5-BDBD and TNP-ATP have similar inhibitory potencies at recombinant human P2X 4 Rs expressed in HEK 293 cells. Our data suggest that 5-BDBD may competitively inhibit the P2X 4 Rs. However, we cannot exclude the possibility that 5-BDBD decreases the ligand-binding affinity of the channels. Such allosteric [42, 43] .
In conclusion, the present study demonstrates that intracellular measurement of Ca 2+ concentration in HEK 293 cells could be a useful method to investigate pharmacological properties of P2X receptor antagonists provided that submicromolar concentrations of ATP are used. 5-BDBD and TNP-ATP have similar inhibitory potencies at human recombinant P2X 4 Rs. Our data show that 5-BDBD shifts the ATP concentration-response curve to the right. This feature differs from the previously described noncompetitive behavior of other P2X 4 R antagonists such as TNP-ATP and paroxetine.
